Cerebain Biotech Corp. announced that Sonos Models Inc. has made progress based on results of research of the first Prototypes of Cerebain's Medical Device Product for the treatment of Alzheimer's. The results of the research suggest the Company has three options for implantable devices with a bias towards having them as non-invasive as possible. The options are comprised of two electro-stim types that have a multitude of variable test parameters that can be changed and modified externally as the testing facility conducts clinical trials on each patient.

It is theorized that if a patient's response to the omentum stimulation is successful, the clinical facility should be able to perform various tests for the purpose of setting "markers" for the patient and then perform the standardized cognitive testing for Alzheimer's patient with the intent of developing a testing matrix.